Australia's most trusted
source of pharma news
Friday, 31 July 2026
Posted 31 July 2026 PM
A heartfelt goodbye from a departing Johnson & Johnson executive was our top story this week, as mystery surrounds his next move to another Big Pharma.
After moving from Sydney to New Jersey for J&J two years ago, Adam Wyldeck is moving on - but where, is still hush-hush. A few enticing hints: he'll be staying in the US. He'll be staying in the industry and will be leading Corporate Affairs. Find out more in: Leader departs after 'hell of a ride'

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.